Phase II study of sequential topotecan and etoposide in patients with intermediate grade non-Hodgkin's lymphoma: A National Cancer Institute of Canada Clinical Trials Group Study

Michael Crump; Stephen Couban; Ralph Meyer; Leona Rudinskas; Brent Zanke; Stefan Gluck; Andrew Maksymiuk; Paul Hoskins; Sarah Matthews; Elizabeth Eisenhauer

doi:10.1080/1042819021000002901

Phase II study of sequential topotecan and etoposide in patients with intermediate grade non-Hodgkin's lymphoma: A National Cancer Institute of Canada Clinical Trials Group Study

Michael Crump, Stephen Couban, Ralph Meyer, Leona Rudinskas, Brent Zanke, Stefan Gluck, Andrew Maksymiuk, Paul Hoskins, Sarah Matthews, Elizabeth Eisenhauer

Research output: Contribution to journal › Article › peer-review

16 Citations (Scopus)

Original language	English
Pages (from-to)	1581-1587
Number of pages	7
Journal	Leukemia and Lymphoma
Volume	43
Issue number	8
DOIs	https://doi.org/10.1080/1042819021000002901
Publication status	Published - 2002
Externally published	Yes

ASJC Scopus Subject Areas

Hematology
Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1080/1042819021000002901

Cite this

Crump, M., Couban, S., Meyer, R., Rudinskas, L., Zanke, B., Gluck, S., Maksymiuk, A., Hoskins, P., Matthews, S., & Eisenhauer, E. (2002). Phase II study of sequential topotecan and etoposide in patients with intermediate grade non-Hodgkin's lymphoma: A National Cancer Institute of Canada Clinical Trials Group Study. Leukemia and Lymphoma, 43(8), 1581-1587. https://doi.org/10.1080/1042819021000002901

Crump, M, Couban, S, Meyer, R, Rudinskas, L, Zanke, B, Gluck, S, Maksymiuk, A, Hoskins, P, Matthews, S & Eisenhauer, E 2002, 'Phase II study of sequential topotecan and etoposide in patients with intermediate grade non-Hodgkin's lymphoma: A National Cancer Institute of Canada Clinical Trials Group Study', Leukemia and Lymphoma, vol. 43, no. 8, pp. 1581-1587. https://doi.org/10.1080/1042819021000002901

@article{61c33622061f47d3a175204fb210718d,

title = "Phase II study of sequential topotecan and etoposide in patients with intermediate grade non-Hodgkin's lymphoma: A National Cancer Institute of Canada Clinical Trials Group Study",

author = "Michael Crump and Stephen Couban and Ralph Meyer and Leona Rudinskas and Brent Zanke and Stefan Gluck and Andrew Maksymiuk and Paul Hoskins and Sarah Matthews and Elizabeth Eisenhauer",

year = "2002",

doi = "10.1080/1042819021000002901",

language = "English",

volume = "43",

pages = "1581--1587",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Informa Healthcare",

number = "8",

}

TY - JOUR

T1 - Phase II study of sequential topotecan and etoposide in patients with intermediate grade non-Hodgkin's lymphoma

T2 - A National Cancer Institute of Canada Clinical Trials Group Study

AU - Crump, Michael

AU - Couban, Stephen

AU - Meyer, Ralph

AU - Rudinskas, Leona

AU - Zanke, Brent

AU - Gluck, Stefan

AU - Maksymiuk, Andrew

AU - Hoskins, Paul

AU - Matthews, Sarah

AU - Eisenhauer, Elizabeth

PY - 2002

Y1 - 2002

UR - http://www.scopus.com/inward/record.url?scp=0036020961&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036020961&partnerID=8YFLogxK

U2 - 10.1080/1042819021000002901

DO - 10.1080/1042819021000002901

M3 - Article

C2 - 12400600

AN - SCOPUS:0036020961

SN - 1042-8194

VL - 43

SP - 1581

EP - 1587

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 8

ER -

Phase II study of sequential topotecan and etoposide in patients with intermediate grade non-Hodgkin's lymphoma: A National Cancer Institute of Canada Clinical Trials Group Study

ASJC Scopus Subject Areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this